Therefore, our above results demonstrated that FDX1 may affect the expression of ALCAM, apoptosis-related proteins, and metastasis-related proteins by regulating FMR1 in ccRCC. The gene discussed is ALCAM; the disease is nonpapillary renal cell carcinoma.